Gene therapy with the p53 tumor suppressor gene in an adenovirus vector data

Gene therapy to replace p53 was safe and showed evidence of clinical activity, researchers reported at the American Society of Clinical Oncology meeting

Read the full 231 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE